Fundraising Fox

Luca Quagliata

Investor

Venture Partner at XGEN Venture

Napoli, IT

About

VP and Global Head of Medical Affairs for the Genetic Science Group at Thermo Fisher Scientific, previously at the Institute of Pathology, University Hospital Basel. Holds a PhD in Vascular Medicine and is a Board-Certified Specialist in Medical Affairs. Joined XGEN in 2023.

Experience

  1. Thermo Fisher ScientificCorporate Head of Diagnostic Medical and Scientific Affairs, Products and Technology Sectorcurrent2026 — presentZug, Zug, Switzerland
  2. Thermo Fisher ScientificVice President, Global Head of Medical and Scientific Affairs2020 — 2026Zug, Switzerland
  3. Thermo Fisher ScientificSenior Director, Global Head of Medical Affairs2019 — 2020
  4. Thermo Fisher ScientificSenior Director, Head of EMEA Medical Affairs2018 — 2019Basel, Basel, Switzerland
  5. XGEN Venture SGR S.p.A.Venture Partnercurrent2023 — presentMilan, Lombardy, Italy
  6. Accreditation Council for Medical Affairs (ACMA)Executive Leadership Committee Membercurrent2021 — present
  7. University of BaselAdjunct Faculty Member2018 — 2019Basel, Basel, Switzerland
  8. Universitätsspital Basel (USB)Senior Director, Diagnostics R&D Unit2017 — 2018Basel, Basel, Switzerland
  9. Universitätsspital Basel (USB)Molecular Diagnostics Team Leader2015 — 2018Basel, Basel, Switzerland
  10. Universität BaselSenior Research Scientist2012 — 2015Basel
  11. National Institutes of HealthVisiting Research Fellow - Post Doc2014Bethesda - USA
  12. University of HeidelbergPhD Student2008 — 2011Heidelberg, Baden-Württemberg, Germany
  13. Fondazione TelethonResearch Fellow2005 — 2007Naples, Campania, Italy

Skills & more

Key Opinion Leaders4European Union3Cross-functional Team Leadership2Molecular Diagnostics7Medical Affairs1Animal Models1Molecular Biology8Biochemistry2Protein Expression2Fluorescence Microscopy2MicroscopyPCR5
+12 moreProtein PurificationLife SciencesBiotechnologyBusiness StrategyMedical DevicesBig DataMarket AccessResearch and Development (R&D)Relationship DevelopmentManagementTeam LeadershipOncology

Languages Inglese · Italiano · Tedesco

  • Board Certified Medical Affairs Specialist — Accreditation Council for Medical Affairs (ACMA)

From Luca's professional profile.

Colleagues at XGEN Venture

Bastiaan van der Baan
Venture Partner at XGEN Venture
Bertil Lindmark
Venture Partner at XGEN Venture
Bianca Benatti
Jr. Analyst at XGEN Venture
Carlotta Marchese
Regulatory and Corporate Affairs Specialist at XGEN Venture
Daniele Scarinci
Founder and Managing Partner at XGEN Venture
Federica Draghi
Founder and Managing Partner at XGEN Venture
Gokhan Batur
Venture Partner at XGEN Venture
Graziano Piredda
Sr. Analyst at XGEN Venture

Frequently asked questions

Who is Luca Quagliata?
VP and Global Head of Medical Affairs for the Genetic Science Group at Thermo Fisher Scientific, previously at the Institute of Pathology, University Hospital Basel. Holds a PhD in Vascular Medicine and is a Board-Certified Specialist in Medical Affairs. Joined XGEN in 2023.
Where does Luca Quagliata work?
Luca Quagliata is Venture Partner at XGEN Venture.
Where did Luca Quagliata go to school?
Luca Quagliata studied at Heidelberg University (Doctor of Philosophy (PhD), Vascular Medicine); Harvard Medical School (HMX Pro - Genetics - Genetic Testing and Sequencing Technologies, Genetics); Università degli Studi di Napoli Federico II (Master of Science - MS, Molecular Medicine / Medical Biotechnology).

Same school

Also attended Heidelberg University44

Mojca SkoberneEntrepreneur in Residence at GV (Google Ventures)Keita Yazakiシニア・アソシエイト (Senior Associate) at CyberAgent CapitalLena ThiedeCo-Founder & General Partner at Planet A VenturesFabian HeilemannFounder & CEO at AENUJan MarchewskiPrincipal at Hitachi VenturesStella PaffenholzSenior Associate at Atlas Venture

+ 38 more

Also attended Harvard Medical School143

Niko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital

+ 137 more

Also attended Università degli Studi di Napoli Federico II15

Fabio CampanileSwitzerland Board Member at MassChallenge MexicoGiuseppe JandoliInvestment Analyst at Apex CapitalLuca CaralviVenture Partner at VentureWave Capital Ltd.Maria LimpidoSenior Associate at StaturaRoberta RiccioLegal Consultant at LVenture GroupMarco ArielloInvestment Committee Member at Growth Engine

+ 9 more

Shared employers

Also worked at University of Basel5

Butrint AliuAnalyst at Pureos BioventuresPer AntonssonVenture Builder at LU InnovationFlorian BitterliInvestor at DeepTech VenturesUlf GrawunderEntrepreneur in Residence at BioMedPartnersAlexander TaylorPh.D. at Inductive Bio

Also worked at Universitätsspital Basel (USB)1

Prof. Dr. Evelyne Yehudit BischofScientific Advisor at Maximon

Also worked at National Institutes of Health60

Jun JeonInvestor at Khosla VenturesUri LopatinInvestor at Khosla VenturesMax ColbertPhysician-Entrepreneur at Medical Excellence CapitalIan ChiangPartner at Flare Capital PartnersGrant VerstandigFounder, Chairman, & CEO at Red Cell IncubationLeela SrinivasanCEO, Parity at Bull City Venture Partners

+ 54 more

Also worked at University of Heidelberg2

Christian PatzeInvestor at M VenturesCatalin VossFounder at Ello